Authors
Poulomi Rudrappa, Lauryn Ursery, Anjallie Hatharashinghe, Dana Giandomenico, Kimberly Enders, Scott Commins, Diana Zychowski, Ross M Boyce
Published in
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Pages 109237. Nov 06, 2026. Epub Nov 06, 2026.
Abstract
To assess the presence of symptoms and immunological profiles after infection with tick-borne spotted fever rickettsiosis (SFR) or ehrlichiosis.
Adults evaluated for acute tick-borne disease completed symptom surveys through 90 days. Cases were classified using standard epidemiological definitions. Participants with alpha-gal sensitization were excluded from the primary analysis. Acute and convalescent cytokine profiles were compared between participants with and without symptoms present at the 90-day timepoint.
Among 71 participants, 37 (52.1%) and 33 (46.5%) met criteria for confirmed or probable ehrlichiosis and SFR, respectively; seven met criteria for both. After excluding 12 participants with alpha-gal sensitization, 15 (50.0%) with ehrlichiosis and 13 (50.0%) with SFR reported at least one moderate or severe symptom at 90 days, compared with one of eight (12.5%) participants classified as not a case. Fatigue and musculoskeletal pain were most common. Participants with symptoms present at 90-days showed higher pro-inflammatory and lower anti-inflammatory cytokine levels, but differences were not statistically significant.
Post-infectious syndromes after tick-borne disease may not be limited to Lyme disease. These preliminary findings support patient-reported experiences and warrant larger studies to define the prevalence, predictors, pathogenesis, and clinical course of possible persistent symptoms.
PMID:
42994791
Bibliographic data and abstract were imported from PubMed on 07 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 16
- Comments 0